report-bg

Contraceptive Devices Market Segmentation by Device Type {Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intra Uterine Device (IUD), and Others}; by Distribution Channel (Hospital, Medical Store, Online Pharmacies, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now Report ID: 3835 | Published Date: Feb 06, 2023

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


RN
Contraceptive Devices Market
Get more information on this report: Request Free Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth


Global Contraceptive Devices Market Regional Synopsis

Market-Growth-Drivers

On the basis of geographical analysis, the global contraceptive devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing population in the region. For instance, as per the report by the World Bank, 1.38 billion people live in India, and 1.411 billion in China, as of 2020. Moreover, government initiatives to promote family planning, is also estimated to boost the market growth.

The market in the North America region is anticipated to gain substantial market share throughout the forecast period on the back of the high health awareness, and presence of major pharmaceutical companies in the region.   

Contraceptive Devices Market Share

Get more information on this reportDownload Sample PDF

The global contraceptive devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook


Market Segmentation

Our in-depth analysis of the global contraceptive devices market includes the following segments:

By Device Type

  • Condoms
  • Diaphragms
  • Cervical Caps
  • Vaginal Rings
  • Intra Uterine Device (IUD) 
  • Others

By Distribution Channel

  • Hospitals
  • Medical Store
  • Online Pharmacies
  • Others

Growth Drivers

  • Increasing Awareness Regarding Unwanted Pregnancy
  • Growing Adoption of Family Planning, and Nuclear Families
  • Concerns Regarding the Rising Global Population

Challenges

  • Side Effects of Contraceptive Devices


Healthcare Expenditure per Capita
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

top-features-companies
    • Allergan PLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Merck & Co.
    • Mylan Laboratories
    • Church & Dwight Co., Inc.
    • Pregna International Limited
    • CooperSurgical, Inc.
    • Pfizer Inc.
    • Reckitt Benckiser Group PLC
    • Teva Pharmaceutical Industries Ltd.
    • The Procter & Gamble Company   

In-the-news

In The News

  • February, 2021: Sandoz announced the acquisition of cephalosporin antibiotics business of GSK, to expand its portfolio to production of antimicrobial drugs.

  • September, 2020: Mylan and Pfizer received approval from European Commission for consolidation of Mylan and Upjohn for distribution of Mylan’s medical products in Europe.


preview-analysis

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


Author Credits:  Radhika Gupta, Shivam Bhutani


Key Questions Answered in the Report

1) What are the major factors driving the growth of the contraceptive devices market?

Ans: The increasing awareness regarding population control, unwanted pregnancy, and family planning, is estimated to boost the market growth.

2) What would be the CAGR of contraceptive devices market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2022 – 2031.

4) Which region will provide more business opportunities for growth of contraceptive devices market in future?

Ans: The North America region is anticipated to provide more business opportunities over the forecast period owing to the efficient healthcare sector in the region.

5) Who are the major players dominating the contraceptive devices market?

Ans: The major players in the market are Merck & Co., Mylan Laboratories, Church & Dwight Co., Inc., Pregna International Limited, CooperSurgical, Inc., Pfizer Inc., Reckitt Benckiser Group PLC, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the contraceptive devices market?

Ans: The market is segmented by device type, distribution channel, and by region.

8) Which sub-segment captures the largest market size in device type segment in the contraceptive devices market?

Ans: The condoms segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.

8) What are the challenges affecting the market growth?

Ans: Various side effects of contraceptive devices are estimated to hamper the market growth.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy